AINewsnow

Lithuania's Biomatter raises $18M Series A for AI enzyme design platform

This story is from 2026-11-12. It is preserved in the archive; the latest stories are on the live feed.

Vilnius-based Biomatter announced on November 12, 2026 an oversubscribed $18 million Series A led by Astanor, with participation from existing investors UVC Partners, Inventure and Metaplanet, to scale its AI enzyme design platform.

Read the full story at The Next Web ↗

Timeline · 2 reports

  1. 2026-11-12 12:03 · Unite.AI
    Biomatter Raises $18M Series A to Expand AI Enzyme Design and Testing
  2. 2026-11-12 09:45 · The Next Web
    Lithuania’s Biomatter raises $18M for AI enzyme design

More stories

  1. Jensen Huang's Nvidia ploughed its vast profits into bankrolling AI startups, suppliers, and chip customers, a web of dependencies that could now unravel (Financial Times) — Techmeme
  2. Anthropic IPO oversubscribed six times as Chinese investors barred — Bloomberg AI
  3. Grounded flights, Microsoft outage and AI turmoil fuel fears of wider tech breakdown — Washington Post AI
  4. Top scorer on South Korea's tax accountant exam admits to cheating with AI — Reuters AI
  5. Research claims China's top AI models were trained on export-banned Nvidia Blackwell chips — The Information AI
  6. Analysts Weigh Nvidia vs. AMD as Top AI Stock Picks After Tech Sell-Off — The Globe and Mail
  7. First AI Music Awards in Los Angeles Hit by Technical Glitches — Techmeme
  8. Opinion: The Flaw at the Heart of Anthropic's I.P.O. — New York Times Technology

Get the daily brief of stories like this at 6:30 every morning →